Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations

References

• Ashcroft, M., & Vousden, K. H. (1999). Regulation of p53 stability. Oncogene, 18(53), 7637–7643. doi:10.1038/sj.onc.1203012
   PubMed Web of Science ®Google Scholar
• Böttger, V., Böttger, A., Garcia-Echeverria, C., Ramos, Y. F. M., van der Eb, A. J., Jochemsen, A. G., & Lane, D. P. (1999). Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene, 18(1), 189–199. doi:10.1038/sj.onc.1202281
   PubMed Web of Science ®Google Scholar
• Baek, S., Kutchukian, P. S., Verdine, G. L., Huber, R., Holak, T. A., Lee, K. W., & Popowicz, G. M. (2012). Structure of the stapled p53 peptide bound to Mdm2. Journal of the American Chemical Society, 134(1), 103–106. doi:10.1021/ja2090367
   PubMed Web of Science ®Google Scholar
• Bas, D. C., Rogers, D. M., & Jensen, J. H. (2008). Very fast prediction and rationalization of pKa values for protein–ligand complexes. Proteins: Structure, Function, and Bioinformatics, 73(3), 765–783. doi:10.1002/prot.22102
   PubMed Web of Science ®Google Scholar
• Bixby, D., Kujawski, L., Wang, S., & Malek, S. N. (2008). The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to Mdm2 inhibitor-mediated apoptosis. Cell Cycle, 7(8), 971–979. doi:10.4161/cc.7.8.5754
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. doi:10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Chen, J. (2018). Functional roles of magnesium binding to extracellular signal-regulated kinase 2 explored by molecular dynamics simulations and principal component analysis. Journal of Biomolecular Structure and Dynamics, 36(2), 351–361. doi:10.1080/07391102.2016.1277783
   PubMed Web of Science ®Google Scholar
• Chen, J., Pang, L., Wang, W., Wang, L., Zhang, J. Z. H., & Zhu, T. (2019a). Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2019.1591304
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, J., Yin, B., Pang, L., Wang, W., & Zhu, W. (2019b). Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free-energy predictions. ACS Chemical Neuroscience, 10(10), 4303–4318. doi:10.1021/acschemneuro.9b00348
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, J., Zhu, W., & Li, G. (2013). A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings. Journal of Computer-Aided Molecular Design, 27(11), 965–974. doi:10.1007/s10822-013-9693-z
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, X., Pang, L., Zhang, J. Z. H., & Zhu, T. (2019c). Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations. Nucleic Acids Research, 47(13), 6618–6631. doi:10.1093/nar/gkz499
   PubMed Web of Science ®Google Scholar
• Cheok, C. F., & Lane, D. P. (2008). New developments in small molecules targeting p53 pathways in anticancer therapy. Drug Development Research, 69(6), 289–296. doi:10.1002/ddr.20261
   Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. doi:10.1063/1.464397
   Web of Science ®Google Scholar
• de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003). Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2. Journal of Biological Chemistry, 278(40), 38315–38324. doi:10.1074/jbc.M213034200
   PubMed Web of Science ®Google Scholar
• Dezi, C., Carotti, A., Magnani, M., Baroni, M., Padova, A., Cruciani, G., … Pellicciari, R. (2010). Molecular interaction fields and 3D-QSAR studies of p53 − MDM2 inhibitors suggest additional features of ligand − target interaction. Journal of Chemical Information and Modeling, 50(8), 1451–1465. doi:10.1021/ci100113p
   PubMed Web of Science ®Google Scholar
• Ding, Q., Zhang, Z., Liu, J.-J., Jiang, N., Zhang, J., Ross, T. M., … Graves, B. (2013). Discovery of RG7388, a potent and selective p53–MDM2 inhibitor in clinical development. Journal of Medicinal Chemistry, 56(14), 5979–5983. doi:10.1021/jm400487c
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. doi:10.1063/1.470117
   Web of Science ®Google Scholar
• Fu, T., Min, H., Xu, Y., Chen, J., & Li, G. (2012). Molecular dynamic simulation insights into the normal state and restoration of p53 function. International Journal of Molecular Sciences, 13(8), 9709–9740. doi:10.3390/ijms13089709
   PubMed Web of Science ®Google Scholar
• Gao, Y., Zhu, T., & Chen, J. (2018). Exploring drug-resistant mechanisms of I84V mutation in HIV-1 protease toward different inhibitors by thermodynamics integration and solvated interaction energy method. Chemical Physics Letters, 706, 400–408. doi:10.1016/j.cplett.2018.06.040
   Web of Science ®Google Scholar
• Gohlke, H., Kiel, C., & Case, D. A. (2003). Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the Ras–Raf and Ras–RalGDS complexes. Journal of Molecular Biology, 330(4), 891–913. doi:10.1016/S0022-2836(03)00610-7
   PubMed Web of Science ®Google Scholar
• Gollner, A., Rudolph, D., Arnhof, H., Bauer, M., Blake, S. M., Boehmelt, G., … McConnell, D. B. (2016). Discovery of novel spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds as chemically stable and orally active inhibitors of the MDM2–p53 interaction. Journal of Medicinal Chemistry, 59(22), 10147–10162. doi:10.1021/acs.jmedchem.6b00900
   PubMed Web of Science ®Google Scholar
• Grace, C. R., Ban, D., Min, J., Mayasundari, A., Min, L., Finch, K. E., … Kriwacki, R. W. (2016). Monitoring ligand-induced protein ordering in drug discovery. Journal of Molecular Biology, 428(6), 1290–1303. doi:10.1016/j.jmb.2016.01.016
   PubMed Web of Science ®Google Scholar
• Graves, B., Thompson, T., Xia, M., Janson, C., Lukacs, C., Deo, D., … Vassilev, L. T. (2012). Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization. Proceedings of the National Academy of Sciences of the United States of America, 109(29), 11788–11793. doi:10.1073/pnas.1203789109
   PubMed Web of Science ®Google Scholar
• Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature, 387(6630), 296–299. doi:10.1038/387296a0
   PubMed Web of Science ®Google Scholar
• Hou, T., McLaughlin, W. A., & Wang, W. (2007). Evaluating the potency of HIV-1 protease drugs to combat resistance. Proteins: Structure, Function, and Bioinformatics, 71(3), 1163–1174. doi:10.1002/prot.21808
   Web of Science ®Google Scholar
• Hou, T., Zhang, W., Wang, J., & Wang, W. (2009). Predicting drug resistance of the HIV-1 protease using molecular interaction energy components. Proteins: Structure, Function, and Bioinformatics, 74(4), 837–846. doi:10.1002/prot.22192
   PubMed Web of Science ®Google Scholar
• Hu, G., Wang, D., Liu, X., & Zhang, Q. (2010). A computational analysis of the binding model of MDM2 with inhibitors. Journal of Computer-Aided Molecular Design, 24(8), 687–697. doi:10.1007/s10822-010-9366-0
   PubMed Web of Science ®Google Scholar
• Hu, G., Yu, X., Bian, Y., Cao, Z., Xu, S., Zhao, L., … Wang, J. (2018). Atomistic analysis of ToxN and ToxI complex unbinding mechanism. International Journal of Molecular Sciences, 19(11), 3524. doi:10.3390/ijms19113524
   Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. doi:10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Ichiye, T., & Karplus, M. (1991). Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins: Structure, Function, and Genetics, 11(3), 205–217. doi:10.1002/prot.340110305
   PubMed Web of Science ®Google Scholar
• Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., & Skeel, R. D. (2001). Langevin stabilization of molecular dynamics. The Journal of Chemical Physics, 114(5), 2090–2098. doi:10.1063/1.1332996
   Web of Science ®Google Scholar
• Jakalian, A., Bush, B. L., Jack, D. B., & Bayly, C. I. (2000). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. Journal of Computational Chemistry, 21(2), 132–146. doi:10.1002/(sici)1096-987x(20000130)21:2 < 132::aid-jcc5 > 3.0.co;2-p
   Web of Science ®Google Scholar
• Jakalian, A., Jack, D. B., & Bayly, C. I. (2002). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. Journal of Computational Chemistry, 23(16), 1623–1641. doi:10.1002/jcc.10128
   PubMed Web of Science ®Google Scholar
• Jeay, S., Ferretti, S., Holzer, P., Fuchs, J., Chapeau, E. A., Wartmann, M., … Sellers, W. R. (2018). Dose and schedule determine distinct molecular mechanisms underlying the efficacy of the p53–MDM2 inhibitor HDM201. Cancer Research, 78(21), 6257–6267. doi:10.1158/0008-5472.CAN-18-0338
   PubMed Web of Science ®Google Scholar
• Jia, X., Wang, M., Shao, Y., König, G., Brooks, B. R., Zhang, J. Z. H., & Mei, Y. (2016). Calculations of solvation free energy through energy reweighting from molecular mechanics to quantum mechanics. Journal of Chemical Theory and Computation, 12(2), 499–511. doi:10.1021/acs.jctc.5b00920
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. doi:10.1063/1.445869
   Web of Science ®Google Scholar
• Joseph, T. L., Madhumalar, A., Brown, C. J., Lane, D. P., & Verma, C. S. (2010). Differential binding of p53 and nutlin to MDM2 and MDMX: Computational studies. Cell Cycle, 9(6), 1167–1181. doi:10.4161/cc.9.6.11067
   PubMed Web of Science ®Google Scholar
• Kallen, J., Goepfert, A., Blechschmidt, A., Izaac, A., Geiser, M., Tavares, G., … Lisztwan, J. (2009). Crystal structures of human MdmX (HdmX) in complex with p53 peptide analogues reveal surprising conformational changes. Journal of Biological Chemistry, 284(13), 8812–8821. doi:10.1074/jbc.M809096200
   PubMed Web of Science ®Google Scholar
• Kallen, J., Izaac, A., Chau, S., Wirth, E., Schoepfer, J., Mah, R., … Furet, P. (2019). Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes. ChemMedChem, 14(14), 1305–1314. doi:10.1002/cmdc.201900201
   PubMed Web of Science ®Google Scholar
• Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science, 274(5289), 948–953. doi:10.1126/science.274.5289.948
   PubMed Web of Science ®Google Scholar
• Levy, R. M., Srinivasan, A. R., Olson, W. K., & McCammon, J. A. (1984). Quasi-harmonic method for studying very low frequency modes in proteins. Biopolymers, 23(6), 1099–1112. doi:10.1002/bip.360230610
   PubMed Web of Science ®Google Scholar
• Li, C., Pazgier, M., Li, C., Yuan, W., Liu, M., Wei, G., … Lu, W. (2010). Systematic mutational analysis of peptide inhibition of the p53–MDM2/MDMX interactions. Journal of Molecular Biology, 398(2), 200–213. doi:10.1016/j.jmb.2010.03.005
   PubMed Web of Science ®Google Scholar
• Li, D., Han, J.-G., Chen, H., Li, L., Zhao, R.-N., Liu, G., & Duan, Y. (2012). Insights into the structural function of the complex of HIV-1 protease with TMC-126: Molecular dynamics simulations and free-energy calculations. Journal of Molecular Modeling, 18(5), 1841–1854. doi:10.1007/s00894-011-1205-2
   PubMed Web of Science ®Google Scholar
• Li, D., Zhang, Y., Zhao, R.-N., Fan, S., & Han, J.-G. (2014). Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation. Journal of Molecular Modeling, 20(2), 2122. doi:10.1007/s00894-014-2122-y
   PubMed Web of Science ®Google Scholar
• Li, G., Shen, H., Zhang, D., Li, Y., & Wang, H. (2016). Coarse-grained modeling of nucleic acids using anisotropic Gay–Berne and electric multipole potentials. Journal of Chemical Theory and Computation, 12(2), 676–693. doi:10.1021/acs.jctc.5b00903
   PubMed Web of Science ®Google Scholar
• Li, H., Robertson, A. D., & Jensen, J. H. (2005). Very fast empirical prediction and rationalization of protein pKa values. Proteins: Structure, Function, and Bioinformatics, 61(4), 704–721. doi:10.1002/prot.20660
   PubMed Web of Science ®Google Scholar
• Li, M., Cong, Y., Li, Y., Zhong, S., Wang, R., Li, H., & Duan, L. (2019a). Insight into the binding mechanism of p53/pDIQ-MDMX/MDM2 with the interaction entropy method. Frontiers in Chemistry, 7(33). doi:10.3389/fchem.2019.00033
   Web of Science ®Google Scholar
• Li, X., Tolbert, W. D., Hu, H.-G., Gohain, N., Zou, Y., Niu, F., … Lu, W. (2019b). Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design. Chemical Science, 10(5), 1522–1530. doi:10.1039/C8SC03275K
   PubMed Web of Science ®Google Scholar
• Lu, S.-Y., Jiang, Y.-J., Zou, J.-W., & Wu, T.-X. (2011). Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX. Journal of Molecular Graphics and Modelling, 30, 167–178. doi:10.1016/j.jmgm.2011.07.003
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. doi:10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006). Modeling the therapeutic efficacy of p53 restoration in tumors. Cell, 127(7), 1323–1334. doi:10.1016/j.cell.2006.12.007
   PubMed Web of Science ®Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. doi:10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Murray, J. K., & Gellman, S. H. (2007). Targeting protein–protein interactions: Lessons from p53/MDM2. Biopolymers, 88(5), 657–686. doi:10.1002/bip.20741
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins: Structure, Function, and Bioinformatics, 55(2), 383–394. doi:10.1002/prot.20033
   PubMed Web of Science ®Google Scholar
• Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., … Lu, W. (2009). Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proceedings of the National Academy of Sciences of the United States of America, 106(12), 4665–4670. doi:10.1073/pnas.0900947106
   PubMed Web of Science ®Google Scholar
• Phan, J., Li, Z., Kasprzak, A., Li, B., Sebti, S., Guida, W., … Chen, J. (2010). Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX. Journal of Biological Chemistry, 285(3), 2174–2183. doi:10.1074/jbc.M109.073056
   PubMed Web of Science ®Google Scholar
• Popowicz, G. M., Czarna, A., Wolf, S., Wang, K., Wang, W., Dömling, A., & Holak, T. A. (2010). Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery. Cell Cycle, 9(6), 1104–1111. doi:10.4161/cc.9.6.10956
   PubMed Web of Science ®Google Scholar
• Reed, D., Shen, Y., Shelat, A. A., Arnold, L. A., Ferreira, A. M., Zhu, F., … Dyer, M. A. (2010). Identification and characterization of the first small molecule inhibitor of MDMX. Journal of Biological Chemistry, 285(14), 10786–10796. doi:10.1074/jbc.M109.056747
   PubMed Web of Science ®Google Scholar
• Robles, A. I., & Harris, C. C. (2001). p53-Mediated apoptosis and genomic instability diseases. Acta Oncologica, 40(6), 696–701. doi:10.1080/02841860152619106
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. doi:10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. doi:10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Sakurai, K., Schubert, C., & Kahne, D. (2006). Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2. Journal of the American Chemical Society, 128(34), 11000–11001. doi:10.1021/ja063102j
   PubMed Web of Science ®Google Scholar
• Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2013). An overview of the Amber biomolecular simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), 198–210. doi:10.1002/wcms.1121
   Web of Science ®Google Scholar
• Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., … Wang, S. (2008). Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proceedings of the National Academy of Sciences of the United States of America, 105(10), 3933–3938. doi:10.1073/pnas.0708917105
   PubMed Web of Science ®Google Scholar
• Shi, D., Bai, Q., Zhou, S., Liu, X., Liu, H., & Yao, X. (2018a). Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity. Proteins: Structure, Function, and Bioinformatics, 86(1), 43–56. doi:10.1002/prot.25401
   PubMed Web of Science ®Google Scholar
• Shi, S., Zhang, S., & Zhang, Q. (2018b). Insight into binding mechanisms of inhibitors MKP56, MKP73, MKP86, and MKP97 to HIV-1 protease by using molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 36(4), 981–992. doi:10.1080/07391102.2017.1305296
   PubMed Web of Science ®Google Scholar
• Shi, S., Zhang, S., & Zhang, Q. (2015). Probing difference in binding modes of inhibitors to MDMX by molecular dynamics simulations and different free energy methods. PLoS One, 10(10), e0141409. doi:10.1371/journal.pone.0141409
   PubMed Web of Science ®Google Scholar
• Shmueli, A., & Oren, M. (2004). Regulation of p53 by Mdm2: Fate is in the numbers. Molecular Cell, 13(1), 4–5. doi:10.1016/S1097-2765(03)00529-X
   PubMed Web of Science ®Google Scholar
• Skalniak, L., Twarda‐Clapa, A., Neochoritis, C. G., Surmiak, E., Machula, M., Wisniewska, A., … Holak, T. A. (2019). A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells. The FEBS Journal, 286(7), 1360–1374. doi:10.1111/febs.14774
   PubMed Web of Science ®Google Scholar
• Song, D., Luo, R., & Chen, H.-F. (2017). The IDP-specific force field ff14IDPSFF improves the conformer sampling of intrinsically disordered proteins. Journal of Chemical Information and Modeling, 57(5), 1166–1178. doi:10.1021/acs.jcim.7b00135
   PubMed Web of Science ®Google Scholar
• Song, L. T., Tu, J., Liu, R. R., Zhu, M., Meng, Y. J., & Zhai, H. L. (2019). Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations. Journal of Biomolecular Structure and Dynamics, 37(11), 2970–2979. doi:10.1080/07391102.2018.1502097
   PubMed Web of Science ®Google Scholar
• Su, J., Liu, X., Zhang, S., Yan, F., Zhang, Q., & Chen, J. (2018). A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36(5), 1212–1224. doi:10.1080/07391102.2017.1317666
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, Y., Shen, M., Tian, S., Xu, L., Pan, P., … Hou, T. (2014a). Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Physical Chemistry Chemical Physics, 16(40), 22035–22045. doi:10.1039/C4CP03179B
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, Y., Tian, S., Xu, L., & Hou, T. (2014b). Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Physical Chemistry Chemical Physics, 16(31), 16719–16729. doi:10.1039/C4CP01388C
   PubMed Web of Science ®Google Scholar
• Tian, S., Zeng, J., Liu, X., Chen, J., Zhang, J. Z. H., & Zhu, T. (2019). Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling. Physical Chemistry Chemical Physics, 21(39), 22103. doi:10.1039/C9CP03598B
   PubMed Web of Science ®Google Scholar
• Twarda-Clapa, A., Krzanik, S., Kubica, K., Guzik, K., Labuzek, B., Neochoritis, C. G., … Holak, T. A. (2017). 1,4,5-Trisubstituted imidazole-based p53–MDM2/MDMX antagonists with aliphatic linkers for conjugation with biological carriers. Journal of Medicinal Chemistry, 60(10), 4234–4244. doi:10.1021/acs.jmedchem.7b00104
   PubMed Web of Science ®Google Scholar
• Uldrijan, S., Pannekoek, W.-J., & Vousden, K. H. (2007). An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. The EMBO Journal, 26(1), 102–112. doi:10.1038/sj.emboj.7601469
   PubMed Web of Science ®Google Scholar
• Vassilev, L. T. (2007). MDM2 inhibitors for cancer therapy. Trends in Molecular Medicine, 13(1), 23–31. doi:10.1016/j.molmed.2006.11.002
   PubMed Web of Science ®Google Scholar
• Vaupel, A., Holzer, P., Ferretti, S., Guagnano, V., Kallen, J., Mah, R., … Furet, P. (2018). In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor. Bioorganic & Medicinal Chemistry Letters, 28(20), 3404–3408. doi:10.1016/j.bmcl.2018.08.027
   PubMed Web of Science ®Google Scholar
• Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., … Jacks, T. (2007). Restoration of p53 function leads to tumour regression in vivo. Nature, 445 (7128), 661. https://www.nature.com/articles/nature05541#supplementary-information. doi:10.1038/nature05541
   PubMed Web of Science ®Google Scholar
• Veprintsev, D. B., Freund, S. M. V., Andreeva, A., Rutledge, S. E., Tidow, H., Cañadillas, J. M. P., … Fersht, A. R. (2006). Core domain interactions in full-length p53 in solution. Proceedings of the National Academy of Sciences of the United States of America, 103(7), 2115–2119. doi:10.1073/pnas.0511130103
   PubMed Web of Science ®Google Scholar
• Vousden, K. H., & Lane, D. P. (2007). p53 in health and disease. Nature Reviews Molecular Cell Biology, 8 (4), 275–283. doi:10.1038/nrm2147
   PubMed Web of Science ®Google Scholar
• Wade, M., Li, Y.-C., & Wahl, G. M. (2013). MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nature Reviews Cancer, 13 (2), 83–96. doi:10.1038/nrc3430
   PubMed Web of Science ®Google Scholar
• Wang, J., Morin, P., Wang, W., & Kollman, P. A. (2001a). Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. Journal of the American Chemical Society, 123(22), 5221–5230. doi:10.1021/ja003834q
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. doi:10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Wang, W., & Kollman, P. A. (2000). Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model11Edited by B. Honig. Journal of Molecular Biology, 303(4), 567–582. doi:10.1006/jmbi.2000.4057
   PubMed Web of Science ®Google Scholar
• Wang, W., Lim, W. A., Jakalian, A., Wang, J., Wang, J., Luo, R., … Kollman, P. A. (2001b). An analysis of the interactions between the Sem − 5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis. Journal of the American Chemical Society, 123(17), 3986–3994. doi:10.1021/ja003164o
   PubMed Web of Science ®Google Scholar
• Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., … Lowe, S. W. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656. https://www.nature.com/articles/nature05529#supplementary-information. doi:10.1038/nature05529
   Google Scholar
• Yan, F., Liu, X., Zhang, S., Su, J., Zhang, Q., & Chen, J. (2018a). Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36(14), 3636–3650. doi:10.1080/07391102.2017.1394221
   PubMed Web of Science ®Google Scholar
• Yan, F., Liu, X., Zhang, S., Su, J., Zhang, Q., & Chen, J. (2018b). Molecular dynamics exploration of selectivity of dual inhibitors 5M7, 65X, and 65Z toward fatty acid binding proteins 4 and 5. International Journal of Molecular Sciences, 19(9), 2496. doi:10.3390/ijms19092496
   PubMed Web of Science ®Google Scholar
• Yan, F., Liu, X., Zhang, S., Su, J., Zhang, Q., & Chen, J. (2019). Electrostatic interaction-mediated conformational changes of adipocyte fatty acid binding protein probed by molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 37(14), 3583–3595. doi:10.1080/07391102.2018.1520648
   PubMed Web of Science ®Google Scholar
• Yang, M., Zhang, X., & Han, K. (2010). Molecular dynamics simulation of SRP GTPases: Towards an understanding of the complex formation from equilibrium fluctuations. Proteins: Structure, Function, and Bioinformatics, 78(10), 2222–2237. doi:10.1002/prot.22734
   PubMed Web of Science ®Google Scholar